All News #Library
Biotech
Odyssey Therapeutics Refiles for $100M IPO in Autoimmune Diseases
19 Apr 2026 //
FIRSTWORD PHARMA
Odyssey Appoints H. Martin to Scientific Advisory Board
10 Mar 2026 //
PHARMIWEB
Odyssey Therapeutics Names Dennis Dean, Ph.D. as EVP
11 Nov 2025 //
BUSINESSWIRE
Odyssey Therapeutics Adds Two Biopharma Veterans To Board
02 Oct 2024 //
BUSINESSWIRE
Odyssey Therapeutics Announces Scientific Advisory Board
27 Sep 2024 //
BUSINESSWIRE
Odyssey Therapeutics Appoints Dr. William Roush As EVP
01 Aug 2024 //
BUSINESSWIRE
Odyssey Therapeutics Announces $101 Million Series C Financing
05 Dec 2023 //
BUSINESSWIRE

Market Place
Sourcing Support